Across TCGA pan-cancer cohorts, CD24P1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of CD24P1’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where CD24P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CD24P1 is over-expressed in tumor.
LUSC are the cancer types where CD24P1 tumor–normal differential expression is most reproducible.